John Snow, Inc.   Report issue

For profit Phase 3
Founded: Boston MA United States (1975)

Organization Overview

First Clinical Trial
2007
NCT00674089
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

JSI Research & Training Institute, Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

chlorhexidine (hibitane) (1 trial)

Drugs in Other Trials (4)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

vitamin a (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5